Product
Allogenic BM-MSCs
1 clinical trial
2 indications
Indication
Chronic Low Back PainIndication
Degenerative Disc DiseaseClinical trial
A Phase 2/3 Prospective, Multicentre Randomized, Double-blind Trial, Comparing Intra-discal Allogeneic Adult BM-MSC Therapy and Sham-treated Controls in Subjects With Chronic LBP Due to Lumbar DDD Unresponsive to Conventional TherapyStatus: Active (not recruiting), Estimated PCD: 2022-05-30